Folate
Compiled from published pharmacological and botanical literature. Not independently verified by Herbuno. Spotted an error or have a correction? Flag it below →
| Compound Class | Water-soluble B vitamin (B9); pteroylglutamate family — naturally occurring folates are reduced polyglutamates |
| Botanical Source | Lemon peel (Citrus limon) — Nimbu Chilka; folate native to the peel matrix |
| Plant Part | Peel |
| Standardisation | 5% folate by HPLC or microbiological assay; form profile should be specified |
| Comparator Forms | Synthetic folic acid (oxidised, fully glutamated); (6S)-5-MTHF salts; folinic acid |
| Solubility / Format | Water-soluble; light- and heat-labile in the reduced forms |
| Regulatory Note | Established NRV and authorised EU health claims; DFE conversion differs between food folate and folic acid |
| Buy from Herbuno | Lemon Peel 5% |
| Origin | Processed / Sourced from India |
| MOQ | R&D 100 g / 250 g (subject to stock) · Pilot batch 1–5 kg · Bulk 10 kg, 25 kg and above |
| Lead Time | Dispatch within 72 hrs from stock · fresh-batch production (typically 50 kg+): 10 working days |
| Documentation | CoA & MSDS standard with every lot; phytosanitary on request |
Name origin: Folate takes its name from the Latin folium, leaf — Herschel Mitchell isolated it from four tons of spinach in 1941, and the leafy-green association has stuck. The distinction that causes most confusion in the trade is that “folate” properly denotes the family of naturally occurring reduced polyglutamate forms, while “folic acid” denotes the fully oxidised monoglutamate that does not occur in food and exists only as a synthetic compound.
Traditional use: Folate has no traditional-medicine record, since megaloblastic anaemia was not linked to a dietary factor until the twentieth century. Citrus peel, the source here, carries an independent record: dried citrus peel is a long-established material in Ayurvedic and Chinese practice, used principally as a digestive, and it remains a culinary staple. Its folate content is a modern analytical observation about a traditional food material rather than the reason it was used.
Research trajectory: Folate research is defined by one of public health's clearest successes — the demonstration that periconceptional folic acid supplementation substantially reduces neural tube defects, which led to mandatory fortification in many countries. The subsequent chapter is more contested: attention has moved to unmetabolised folic acid appearing in circulation, to MTHFR polymorphisms, and to whether reduced folate forms should displace folic acid. That debate is where the commercial interest now sits and where the evidence is least tidy.
Commercial source: Folic acid is manufactured synthetically and is inexpensive. Reduced folate salts, principally (6S)-5-MTHF calcium, glucosamine or dicholine salts, are also synthesised and command a premium. Plant-derived folate concentrates are a third category in which the vitamin is present in its natural reduced forms within a food matrix — a genuine chemical distinction from folic acid rather than a marketing one, though as set out below it does not automatically translate into a clinical advantage.
Evidence for Folate Applications
The metabolic distinction is real and well characterised. Folic acid must be reduced by dihydrofolate reductase before entering the folate cycle, and that enzyme's capacity is limited: detectable unmetabolised folic acid appears in serum when the oral dose exceeds roughly 200 µg. [5-MTHF PK study] Naturally occurring folates and (6S)-5-MTHF salts bypass this step entirely, since they are already reduced. This is chemistry, not marketing, and it is the legitimate foundation of the natural-folate position. Claim strength: High.
The unmetabolised folic acid finding is reproducible in a directly relevant population. In a randomised trial, 60 pregnant women received 0.6 mg/day of either folic acid or (6S)-5-MTHF from 8–21 weeks gestation, with human milk sampled at about one week postpartum and quantified by LC-MS/MS; folic acid supplementation increased unmetabolised folic acid in human milk relative to 5-MTHF, at the expense of reduced folate forms. [Cochrane 2023] Since 5-MTHF normally constitutes the majority of milk folate, shifting that profile toward an inactive form is a substantive observation. Claim strength: High.
Where the story becomes genuinely more complicated — and where most commercial material stops — is at clinical outcomes. In a randomised double-blind trial, 220 women with three or more idiopathic recurrent abortions took 1 mg/day of either 5-MTHF or folic acid from at least eight weeks preconception to week 20. Serum folate rose significantly more in the 5-MTHF group, but there was no significant difference in abortion rate, and plasma homocysteine reduction did not differ between groups. The authors concluded the results do not support any beneficial effect of 5-MTHF over folic acid in these women with any MTHFR C677T or A1298C polymorphism. [Hekmatdoost 2015] Claim strength: Moderate.
That result deserves emphasis because it cuts directly against the dominant commercial narrative around MTHFR. Better pharmacokinetics and higher serum folate did not translate into a better clinical outcome, even in the genotype subgroup where the theory predicts it should. A formulator choosing a reduced folate form on biochemical grounds is on solid ground; a brand claiming superior outcomes for MTHFR carriers is not, on this evidence. Claim strength: Moderate.
One safety consideration applies to all folate forms and is often omitted: high folate intake can mask the haematological signs of vitamin B12 deficiency while neurological damage progresses, which is the basis for upper intake levels on folic acid. Whether reduced folates carry the same masking risk has not been settled — European authorities have acknowledged the pharmacokinetic differences without concluding that 5-MTHF salts would impart such effects. Prudent formulation pairs folate with adequate B12 regardless of form. Claim strength: Moderate.
Sourcing natural folate: A 5% folate concentrate from lemon peel is available from Herbuno, with lot-specific assay, CoA and MSDS. View Folate 5% (Lemon Peel) →
Dosage & Formulator Specification
Production route. Citrus peel is extracted and concentrated to a 5% folate specification. Naturally occurring folates in plant material are predominantly reduced polyglutamate forms, which are considerably less stable than synthetic folic acid — they are sensitive to heat, light, oxygen and acid pH. Process control during extraction and drying therefore determines a great deal about what survives into the finished material, and it is a legitimate question to ask a supplier about, rather than something to infer from the assay value alone.
Analytical standardisation. Total folate may be determined by microbiological assay or by HPLC. The important specification point for a natural folate is the form profile: whether the material is characterised only as total folate or is resolved into 5-MTHF and other reduced forms. If the natural-folate position is commercially load-bearing for your product, request form-resolved analysis rather than a total figure, since total folate alone does not evidence the claim you are making. Dietary Folate Equivalent conversion factors differ between food folate and folic acid and must be applied correctly in label calculations.
Regulatory and handling context. Folate has an established Nutrient Reference Value in the EU and authorised health claims including contribution to maternal tissue growth during pregnancy, normal amino acid synthesis, normal blood formation, normal homocysteine metabolism, and reduction of tiredness and fatigue. Tolerable upper intake levels are set on folic acid specifically, on the basis of masking B12 deficiency. Because the reduced folates are labile, store cold, dark and dry in sealed containers and minimise processing exposure; stability is the dominant handling consideration for this material.
Formulation behaviour. At 5%, delivering 200 µg of folate requires 4 mg of material, which is a workable inclusion but demands validated blend uniformity at that scale. The critical design issue is stability rather than dose: natural reduced folates degrade under conditions that synthetic folic acid tolerates comfortably, so a formulation and packaging system validated for folic acid should not be assumed adequate here. Generate matrix-specific stability data and design overage from that data rather than from a generic factor. Co-formulation with vitamin B12 is advisable on the masking grounds noted above, and with vitamin C, which can help protect reduced folates from oxidation.
Frequently Asked Questions — Folate
Folate denotes the naturally occurring reduced polyglutamate forms found in food; folic acid is the fully oxidised synthetic monoglutamate that does not occur naturally. Folic acid must be reduced by dihydrofolate reductase before it can enter the folate cycle, and that enzyme's capacity is limited, with unmetabolised folic acid appearing in serum above roughly 200 micrograms oral dose. Natural folates and 5-MTHF bypass that step because they are already reduced.
The evidence does not support that claim, and we would rather say so plainly. A randomised double-blind trial in 220 women with recurrent miscarriage found that although serum folate rose significantly more with 5-MTHF than folic acid, there was no difference in abortion rate and no difference in homocysteine reduction, and the authors concluded there was no beneficial effect of 5-MTHF regardless of MTHFR C677T or A1298C genotype. The biochemical rationale is sound; the outcome claim is not established.
When folic acid intake exceeds the capacity of dihydrofolate reductase, unmetabolised folic acid appears in circulation. In a randomised trial in pregnant women, folic acid supplementation increased unmetabolised folic acid in human milk relative to 5-MTHF, at the expense of reduced folate forms. Since 5-MTHF is normally the predominant folate in milk, that shift is a substantive finding. The long-term significance of circulating unmetabolised folic acid remains under investigation.
Considerably less stable, and this is the dominant formulation consideration. Naturally occurring reduced folates are sensitive to heat, light, oxygen and acid pH in ways that synthetic folic acid is not. A formulation and packaging system validated for folic acid should not be assumed adequate for a natural folate material. Generate stability data in your specific matrix and base any overage on that rather than on a generic factor.
Request form-resolved analysis distinguishing 5-MTHF from other folate forms, rather than accepting a total folate figure. If your product's commercial position rests on natural folate, a total assay does not substantiate that claim on its own. Also confirm which Dietary Folate Equivalent conversion factor applies, since factors differ between food folate and folic acid and this affects label calculation directly.
Every lot ships with a Certificate of Analysis and MSDS as standard, with phytosanitary certification on request. R&D quantities are available at 100 g and 250 g subject to stock, pilot batches at 1–5 kg, and bulk at 10 kg, 25 kg and above. Stock orders dispatch within 72 hours; fresh-batch production, typically 50 kg and above, runs to about 10 working days. Material is processed and sourced in India. Given folate lability, we recommend discussing storage and shipping conditions for longer transit routes.
Related compounds: Vitamin B12 · Vitamin C · Betaine
Claim strength scale: High — consistent human data or established biochemistry. Moderate — supportive human data with limitations. Emerging — mechanistic or preliminary evidence only.